🔎 Trials Near Me

Home › Neuroendocrine Carcinoma › Tennessee

Pag-aaral pangklinika para sa Neuroendocrine Carcinoma sa Tennessee

4 pag-aaral para sa Neuroendocrine Carcinoma ang naghahanap ng mga kalahok sa mga site sa Tennessee.

Mga Lungsod sa Tennessee

Opisyal na teksto ng pag-aaral (English)

A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)

  • Sarah Cannon Research Institute (SCRI), Nashville
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT07488923

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

  • Erlanger Health, Inc, Chattanooga
  • The West Clinic, Germantown
  • SCRI Oncology Partners, Nashville
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 5, 2026 · NCT06330064

A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer

  • Sarah Cannon Research Institute - Oncology Partners, Nashville
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 9, 2026 · NCT07174583

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

  • Baptist Memorial Hospital Baptist Cancer Center, Memphis
Nagre-recruitPhase 1/2
Edad 12 pataas · Lahat ng kasarian · Na-update May 27, 2026 · NCT03093116

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.